Lichenoid Eruption During Chronic Hepatic C Treatment with Interferon-Alpha 2 a Plus Ribavirin

被引：0
作者：
Sahnoun, R. [1 ]
Kastalli, S. [1 ]
Charfi, O. [1 ]
Zaiem, A. [1 ]
Lakhal, M. [1 ]
Daghfous, R. [1 ]
El Aidli, S. [1 ]
机构：
[1] Natl Ctr Pharmacovigilance, Tunis, Tunisia
来源：
DRUG SAFETY | 2013年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
[41]   Alpha-interferon plus ribavirin for the treatment of chronic hepatitis C in patients who have failed treatment with alpha-interferon. [J].
Kwo, PY ;
Pound, DC ;
Fields, S ;
Glowinski, EA ;
Chalasani, N ;
Cho, WK ;
Crabb, DW ;
Cummings, OW ;
Imperiale, T ;
Lumeng, L ;
McGill, JM ;
Ness, R .
HEPATOLOGY, 1999, 30 (04) :368A-368A
[42]   COST-EFFECTIVENESS ANALYSIS OF PEG-INTERFERON ALPHA-2A PLUS RIBAVIRIN VERSUS CONVENTIONAL INTERFERON ALPHA-2A PLUS RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C IN CHINA [J].
Chen, W. ;
Wei, L. .
VALUE IN HEALTH, 2011, 14 (07) :A280-A280
[43]   Peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive Egyptian patients [J].
El-Wakil, R. M. ;
Montasser, M. F. ;
Mansour, M. A. ;
Salman, T. A. ;
EL-Batanony, M. H. ;
Helail, E. H. ;
Shehata, K. O. ;
Attallah, K. M. ;
Madwar, M. A. .
JOURNAL OF CLINICAL VIROLOGY, 2006, 36 :S142-S143
[44]   Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection [J].
Tsubota, A ;
Hirose, Y ;
Izumi, N ;
Kumada, H .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) :360-367
[45]   Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity [J].
Yasui, Shin ;
Fujiwara, Keiichi ;
Yokosuka, Osamu .
DIGESTIVE AND LIVER DISEASE, 2011, 43 (08) :666-667
[46]   Combined ribavirin and interferon-alpha for the treatment of chronic hepatitis C - Where do we stand today? [J].
Renner, EL .
SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (1-2) :8-10
[47]   The association of fatigue with poor virologic response in patients receiving interferon-alpha plus ribavirin for the treatment of hepatitis C [J].
Raison, CL ;
Pariante, CM ;
Capuron, L ;
Chen, B ;
Woolwine, BJ ;
Bruno, C ;
Jacobson, I ;
Miller, AH .
HEPATOLOGY, 2005, 42 (04) :676A-676A
[48]   Tongue hyperpigmentation during interferon-alpha and ribavirin therapy [J].
Aguayo-Leiva, Ingrid ;
Perez, Bibiana ;
Salguero, Irene ;
Jaen, Pedro .
EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (03) :291-292
[49]   Lymphocyte subsets in interferon treatment or interferon plus ribavirin treatment of chronic hepatitis C [J].
Macedo, G ;
Correia, A ;
Fernandes, N ;
Sarmento, J ;
Vale, A ;
Ramos, JP ;
Candeias, J ;
Ribeiro, T .
HEPATOLOGY, 1998, 28 (04) :704A-704A
[50]   Comparision of the Side Effects Due To Interferon Alpha 2A Plus Ribavirin and Pegylated Interferon Alpha 2A Plus Ribavirin Combinations For Chronic Hepatitis C Infection [J].
Ural, Onur ;
Demir, Nazlim Aktug ;
Sumer, Sua ;
Ural, Gaye ;
Balci, Mehmet .
TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2010, 27 (03) :261-264
12345